Mariner
NVCR icon

Mariner’s NovoCure NVCR Stock Holding History

Mariner’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Buy
67,400
+49,805
+283% +$754K ﹤0.01% 1940
2026
Q1 		$192K Sell
17,595
-2,773
-14% -$34.6K ﹤0.01% 3175
2025
Q4 		$264K Sell
20,368
-3,182
-14% -$40.8K ﹤0.01% 2949
2025
Q3 		$304K Buy
23,550
+12,460
+112% +$166K ﹤0.01% 2794
2025
Q2 		$197K Sell
11,090
-1,651
-13% -$28.8K ﹤0.01% 3061
2025
Q1 		$227K Buy
12,741
+4,110
+48% +$93.3K ﹤0.01% 2891
2024
Q4 		$257K Buy
+8,631
New +$183K ﹤0.01% 2770
2023
Q1 		– Sell
-6,252
Closed -$459K – 2852
2022
Q4 		$459K Sell
6,252
-325
-5% -$24.5K ﹤0.01% 1705
2022
Q3 		$500K Buy
+6,577
New +$513K ﹤0.01% 1420

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Mariner's NVCR Position: Q2 2026 in Review

Mariner increased its NovoCure (NVCR) stake by 283% in Q2 2026, buying an estimated $754K and bringing the position to 67,400 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1940.

Mariner first reported a position in NVCR in Q3 2022 and has held it in 9 quarters since. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Mariner held 67,400 shares of NovoCure worth $1.02M as of Q2 2026.
  • Mariner bought 49,805 NovoCure shares in Q2 2026, an estimated $754K.
  • NovoCure made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1940 holding.
  • Mariner first reported a position in NovoCure in Q3 2022 and has held it in 9 quarters since.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.